Amanote Research
Register
Sign In
366. Combining Delivery of GLP-1 Gene Expressing Plasmid and DPP-4 Gene Silencing siRNA Using Chitosan-Based Nanoparticles for Type-2 Diabetes Treatment
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35379-5
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
Biocompatible Glycol Chitosan-Based Nanoparticles for Gene Delivery System
Polymer (Korea)
Polymers
Materials Chemistry
Plastics
Chemical Engineering
Enhanced Gene Delivery and siRNA Silencing by Gold Nanoparticles Coated With Charge-Reversal Polyelectrolyte
ACS Nano
Materials Science
Nanoscience
Engineering
Nanotechnology
Astronomy
Physics
Emerging Technologies to Achieve Oral Delivery of GLP-1 and GLP-1 Analogs for Treatment of Type 2 Diabetes Mellitus (T2DM)
Canadian Journal of Biotechnology
Dendrimers as Carriers for siRNA Delivery and Gene Silencing: A Review
The Scientific World Journal
Biochemistry
Medicine
Genetics
Molecular Biology
Environmental Science
Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
Non-Toxic Delivery and Gene Silencing by siRNA-Peptide Complex
Combining Hyaluronic Acid With Chitosan Enhances Gene Delivery
Journal of Nanomaterials
Materials Science
Nanotechnology
Nanoscience
Need for Streamlined Use of DPP-4 Inhibitors in the Treatment of Type 2 Diabetes
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Qtern: DPP-4 and SGLT2 Inhibitor Combination for Type 2 Diabetes
Prescriber
Pharmacology
